Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Craig Scheiblauer
    Junior Member
    • Dec 2012
    • 1

    #1

    Hello - Introduction

    My name is Craig Scheiblauer and I've been recruiting in the Life Sciences industry for ten years. I'm excited to be a part of this community, thank you for the opportunity.

    One of my Clients is located in the South Central US and they are developing a cutting edge NGS sequencing platform.

    A Next Generation Sequencing (NGS) Scientist, Application Specialist, Programmer/Developer and Director of Bioinformatics position is available.

    These positions carry with them the primary responsibility of applying knowledge of NGS applications and technologies to the development of a cutting-edge sequencing platform. Experience using NGS in research or diagnostics and a broad understanding of molecular genetics and genomics is needed to be considered for these positions.

    The Programmer/Developer position requires a knowledge of signal processing, normalization, and pre-fastq files.

    Please contact me to discuss any of these positions in more detail.

    Thank you.

    Craig Scheiblauer
    Prinicipal, Executive Search Consultant
    [email protected]
    805-453-6583 cell
    805-203-6525 office
    Craig

    Craig Scheiblauer
    Principal, Executive Search Consultant
    [email protected]
    805-453-6583 cell
    805-203-6525 office
  • adaptivegenome
    Super Moderator
    • Nov 2009
    • 436

    #2
    Welcome to SEQanswers. I wonder if you are talking about LaserGen

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    17 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...